Recruiting for “Cures”-funded positions resulted in two hires, then got an HHS review; onboarding time should be reduced significantly, but finding the money to pay the higher salaries remains a challenge under the new process.
The US FDA has officially launched its “Reimagining Hiring” pilot program approximately one year after Commissioner Scott Gottlieb announced the creation of a streamlined recruitment process to fill open user fee-funded positions at the agency.
The official start of the pilot program on July 30 was postponed approximately six months to allow more time for FDA Acting Associate Commissioner for Scientific and Clinical Recruitment Melanie Keller to hire and train her 30-person team
Stay up to date on regulatory guidelines from around the world with the Pink Sheet’s Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Decision in AstraZeneca’s lawsuit against the Health and Human Services Department is a precedent-setting victory for the government and a blow to manufacturer efforts to block the price negotiation program.
Advisory committee for Capricor’s deriamocel planned, regenerative medicine advanced therapy designations proliferate for osteoarthritis, and the ranks of dual RMAT/breakthrough therapy designation holders grow.
